Léčba erlotinibem nemocných s nemalobuněčnými karcinomy plic - efekt snížené dávky při závažných nežádoucích účincích
| Title in English | Erlotinib therapy of patients with NSCLC - dose reduction in patients with severe adverse reactions |
|---|---|
| Authors | |
| Year of publication | 2010 |
| Type | Article in Proceedings |
| Conference | XXXIV. Brněnské onkologické dny |
| MU Faculty or unit | |
| Citation | |
| Field | Pneumology |
| Keywords | erlotinib; NSCLC; dose reduction; adverse reaction |
| Description | This contribution to the conference was dedicated to the analysis of dose reduction effect in patients treated for NSCLC with erlotinib who suffered from severe adverse reactions. |
| Related projects: |